One study in 9 patients with CFRD-FH+ used insulin pump therapy for 6 months achieving a significant reduction of HbA1c, fasting and postprandial blood glucose, without severe hypoglycemia events (41) (evidence Moderate). The gene discussed is INS; the disease is Hypoglycemia.